Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Click Therapeutics

Request full access

Develops and commercializes software as prescription medical treatments for people with unmet medical needs

New York City, United StatesFounded 2012Biotech & Life Sciences

About Click Therapeutics

Click Therapeutics is a biotechnology startup that operates in the digital health sector, specifically in the emerging field of digital therapeutics. The company develops, validates, and commercializes software as prescription medical treatments for patients with unmet medical needs. This means they create software applications that are used like medicine, either on their own or alongside traditional treatments, to help patients manage their health conditions.

The company's business model is based on the development of these software applications, which are designed to alter the cognitive and neurobehavioral mechanisms that underlie various diseases. These applications are rigorously tested through randomized, controlled trials to ensure their safety and effectiveness. Once validated, the company seeks clearance from the FDA to market these apps as class II medical devices.

Click Therapeutics' revenue comes from physicians who prescribe their apps and from payers who reimburse for them. The company also uses real-world evidence to continuously improve and personalize their applications.

One of their notable collaborations is with Boehringer Ingelheim, a leading pharmaceutical company, to develop and commercialize a novel prescription digital therapeutic to aid in the treatment of schizophrenia. This partnership is worth $500 million, indicating the significant potential of digital therapeutics in the healthcare market.

The company's leadership team includes CEO David B. Klein, CFO, CTO, Chief Strategy Officer Austin C. Speier, and Chief Medical Officer Shaheen Lakhan, MD, PhD, FAAN, among others.

Source: Dealroom company data

At a glance

Status
Operational
Employees
117
Open positions
2
Dealroom signal
62.5/100
Industry
Health
Sub-industry
Pharmaceutical, Medical Devices
Sector
Biotechnology, Mental Health, Sustainable Development Goals, Digital Therapeutics, Tech for Biotech and Pharma, Tech for Patients, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
SaaS

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Apr 2026 $50M $200M Boehringer Ingelheim ↗
LATE VCOther financing Mar 2025 $0 — Dassault Systemes ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Click Therapeutics website traffic

Latest recorded traffic for Click Therapeutics is 10K monthly website visits, up 26.6% over the last three months. Click Therapeutics's team declined 23% over the past year.

Latest monthly visits10K 3-month web change+26.6% 1-year team growth-23%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Click Therapeutics in the New York City ecosystem

Live from Dealroom

The Click Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A8 investors entered at this stage

  • Magellan Health Services
  • Sanofi Ventures
  • H.I.G. HealthBridge
  • Accelmed
  • Hikma Ventures
  • Revelation Partners
  • Health Catalyst Capital
  • Ridgetop Health

Series B and later5 investors entered at this stage

  • K2 HealthVentures
  • Standard Treasury
  • HSBC Innovation Banking
  • Dassault Systemes
  • Boehringer Ingelheim
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Click Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.